Premium
[P3–014]: INVESTIGATION OF PHARMACOKINETIC DRUG‐DRUG INTERACTION FOLLOWING ORAL ADMINISTRATION OF BI 409306 AND DONEPEZIL IN HEALTHY SUBJECTS
Author(s) -
Wunderlich Glen,
Schultheis Christian,
Link Jasmin,
Schultz Armin,
Voelk Claudia
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.1827
Subject(s) - donepezil , cmax , pharmacokinetics , pharmacology , crossover study , medicine , area under the curve , adverse effect , dementia , disease , placebo , alternative medicine , pathology
P3-014 INVESTIGATION OF PHARMACOKINETIC DRUG-DRUG INTERACTION FOLLOWING ORAL ADMINISTRATION OF BI 409306 AND DONEPEZIL IN HEALTHY SUBJECTS Glen Wunderlich, Christian Schultheis, Jasmin Link, Armin Schultz, Claudia Voelk, Boehringer Ingelheim (Canada) Ltd, Burlington, ON, Canada; Boehringer Ingelheim Pharma GmbH&Co. KG, Biberach an der Riss, Germany; CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany. Contact e-mail: glen.wunderlich@ boehringer-ingelheim.com
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom